Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Triplitt

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical Diabetes : a Publication of the American Diabetes Association|November 8, 2017
How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?Curtis Triplitt, Debbie Hinnen, Virginia Valentine
The Annals of Pharmacotherapy|October 19, 2024
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes ManagementJennifer Goldman, Curtis Triplitt, Diana Isaacs
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic OutcomesCarolina Solis-Herrera, Eugenio Cersosimo, Curtis Triplitt
Vascular Health and Risk Management|September 23, 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatmentCurtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Jornal Brasileiro De Nefrologia|March 29, 2014
Inhibition of renal glucose reabsorption as a novel treatment for diabetes patientsEugenio Cersosimo, Carolina Solis-Herrera, Curtis Triplitt
Clinical Diabetes : a Publication of the American Diabetes Association|January 17, 2024
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide ExperienceCarolina Solis-Herrera, Michael P Kane, Curtis Triplitt
Expert Opinion on Drug Delivery|December 23, 2006
First approved inhaled insulin therapy for diabetes mellitusRucha Jani, Curtis Triplitt, Charles Reasner, et al.
Physiological Reports|August 21, 2014
Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferationEugenio Cersosimo, Xiaojing Xu, Sikarin Upala, et al.
Journal of Managed Care Pharmacy : JMCP|February 22, 2008
The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomesCurtis Triplitt, Janet B McGill, Daniel Porte, et al.
Diabetes Care|November 25, 2004
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjectsEstela Wajcberg, Yoshinori Miyazaki, Curtis Triplitt, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical Diabetes : a Publication of the American Diabetes Association|November 8, 2017
How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?Curtis Triplitt, Debbie Hinnen, Virginia Valentine
The Annals of Pharmacotherapy|October 19, 2024
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes ManagementJennifer Goldman, Curtis Triplitt, Diana Isaacs
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic OutcomesCarolina Solis-Herrera, Eugenio Cersosimo, Curtis Triplitt
Vascular Health and Risk Management|September 23, 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatmentCurtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Jornal Brasileiro De Nefrologia|March 29, 2014
Inhibition of renal glucose reabsorption as a novel treatment for diabetes patientsEugenio Cersosimo, Carolina Solis-Herrera, Curtis Triplitt
Clinical Diabetes : a Publication of the American Diabetes Association|January 17, 2024
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide ExperienceCarolina Solis-Herrera, Michael P Kane, Curtis Triplitt
Expert Opinion on Drug Delivery|December 23, 2006
First approved inhaled insulin therapy for diabetes mellitusRucha Jani, Curtis Triplitt, Charles Reasner, et al.
Physiological Reports|August 21, 2014
Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and proliferationEugenio Cersosimo, Xiaojing Xu, Sikarin Upala, et al.
Journal of Managed Care Pharmacy : JMCP|February 22, 2008
The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomesCurtis Triplitt, Janet B McGill, Daniel Porte, et al.
Diabetes Care|November 25, 2004
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjectsEstela Wajcberg, Yoshinori Miyazaki, Curtis Triplitt, et al.
Pageof 6